Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 Y220C mutations in patients with myeloid malignancies.

Leukemia & lymphoma - 1 Oct 2024

Gener-Ricos Georgina, Bewersdorf Jan P, Loghavi Sanam, Bataller Alex, Goldberg Aaron D, Sasaki Koji, Famulare Christopher, Takahashi Koichi, Issa Ghayas C, Borthakur Gautam, Kadia Tapan M, Short Nicholas J, Senapati Jayastu, Carter Bing Z, Patel Keyur P, Kantarjian Hagop, Andreeff Michael, Stein Eytan M, DiNardo Courtney D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer-related Molecular Pathways
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Disorders

Share to Sarcoma Diagnosis and Treatment

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 38856690
DOI: 10.1080/10428194.2024.2363440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 Y220C mutations in patients with myeloid malignancies.PMID 38856690Read ↗

TP53 mutation screening for patients at risk of myeloid malignancySemantic proximity Read ↗

TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment.Semantic proximity Read ↗

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Semantic proximity Read ↗

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17pSemantic proximity Read ↗

A clinical guide to TP53 mutations in myeloid neoplasms.Semantic proximity Read ↗

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.Semantic proximity Read ↗

Germline CHEK2 mutations in patients with myeloid neoplasms.Semantic proximity Read ↗

p53 in hematologic malignancies.Semantic proximity Read ↗

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.Semantic proximity Read ↗

Receptor tyrosine kinase mutations in myeloid neoplasms.Semantic proximity Read ↗

Acute myeloid leukemia with TP53 germ line mutationsSemantic proximity Read ↗

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.